Annual Growth in Roche's Sequencing Business Fueled by GS Junior Sales; New Products Planned for 2011 | GenomeWeb

By Monica Heger

This story was originally published on Feb. 2.

Roche realized a 17 percent revenue increase in its sequencing and array business last year, driven largely by sales of its GS Junior, the company reported last week.

The company's Applied Science business area, which includes its sequencing and array businesses, reported CHF 868 million in sales, which was flat compared to 2009 but represented a 4 percent year-over-year increase in local currencies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.